CAS 1188371-47-2

CKD-516

Description:

CKD-516, identified by its CAS number 1188371-47-2, is a chemical compound that belongs to the class of small molecules. It is primarily recognized for its potential application in the field of medicinal chemistry, particularly as an investigational drug. The compound exhibits properties that may influence various biological pathways, making it of interest in therapeutic research. CKD-516 is characterized by its specific molecular structure, which contributes to its biological activity. While detailed pharmacokinetic and pharmacodynamic profiles are still under investigation, initial studies suggest that it may interact with certain cellular targets, potentially leading to effects on cell proliferation and survival. As with many investigational compounds, the safety and efficacy of CKD-516 are subjects of ongoing clinical trials, and its full therapeutic potential is yet to be established. Researchers continue to explore its mechanisms of action and possible applications in treating specific diseases, particularly in oncology.

Formula: C₂₆H₂₈N₆O₅S

Synonyms:

• CKD-516
• (2S)-2-amino-3-methyl-N-[4-[3-(1,2,4-triazol-1-yl)-4-(3,4,5-trimethoxybenzoyl)phenyl]-1,3-thiazol-2-yl]butanamide
• Valecobulin
• Butanamide, 2-amino-3-methyl-N-[4-[3-(1H-1,2,4-triazol-1-yl)-4-(3,4,5-trimethoxybenzoyl)phenyl]-2-thiazolyl]-, (2S)-

Valecobulin

CAS: 1188371-47-2

Valecobulin is a potent β-tubulin polymerization inhibitor. Valecobulin is a valine prodrug of (S516) and an avascular disrupting compound.

Formula: C₂₆H₂₈N₆O₅S

Purity: 98%

Color and Shape: Solid

Molecular weight: 536.6

Ref: TM-T13278L